Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection
about
schizont egress antigen-1schizont egress antigen-1, putativeschizont egress antigen-1, putativeschizont egress antigen-1, putativeschizont egress antigen-1schizont egress antigen-1, putativeschizont egress antigen-1, putativeschizont egress antigen-1, putativeschizont egress antigen-1, putativeschizont egress antigen-1, putativeschizont egress antigen-1, putative
P1343
Novel approaches to identify protective malaria vaccine candidatesExpanding the antimalarial toolkit: Targeting host-parasite interactionsPhosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion.Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite ProteinConformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug TherapyHost-Parasite Interactions in Human Malaria: Clinical Implications of Basic ResearchPlasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.Chemical biology strategies for posttranslational control of protein function.Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate.Malaria Vaccines: Moving Forward After Encouraging First Steps.Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infectionDistinct transcriptional responses elicited by unfolded nuclear or cytoplasmic protein in mammalian cells.Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vγ9Vδ2 T Cells.Biosignatures of Exposure/Transmission and ImmunityImmunogenicity and protective potential of a Plasmodium spp. enolase peptide displayed on archaeal gas vesicle nanoparticles.IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal StudyVaccine candidate discovery for the next generation of malaria vaccines.Large screen approaches to identify novel malaria vaccine candidates.Preparing for future efficacy trials of severe malaria vaccinesTargets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Progress and prospects for blood-stage malaria vaccinesNew insight-guided approaches to detect, cure, prevent and eliminate malaria.The stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines.Signaling transcript profile of the asexual intraerythrocytic development cycle of Plasmodium falciparum induced by melatonin and cAMP.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1.High-Density Peptide Arrays for Malaria Vaccine Development.Editorial Commentary: Toward a Better Malaria Vaccine: Understanding How Antibodies to Malaria Protect Against Disease.Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1.Mechanisms of naturally acquired immunity to P. falciparum and approaches to identify merozoite antigen targets.Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trialPD-1 deficiency promotes TFH cells expansion in ITV-immunized mice by upregulating cytokines secretionTransient antibody-antigen interactions mediate the strain-specific recognition of a conserved malaria epitope
P2860
Q56571216-387CF0B9-0A4F-4B79-B56A-B3B3215323BCQ56729085-8CE92CC1-1F0E-4F8C-9C14-19F784C20C38Q59735960-97E79444-2B93-491E-AE3F-688CF63A85F7Q59874844-9FBD110E-4FB6-486C-AED3-5F89E59CB2F6Q59909398-4C2FE3CB-AA08-420E-812A-B18F7471A193Q59955315-68B1E707-B8D6-4E9B-9992-215A318D4B4FQ59957403-2663549D-04D3-4134-9C2B-E858DC130AF0Q59976386-ACB3B9C2-6E27-47CB-B125-9179202E424EQ59977239-0B89E330-786B-4220-86AA-56D9C5E8798BQ59982693-B141234D-9131-4D70-B0C6-5E1FEF23B61EQ59999484-306F0D1D-F98F-4F67-93F4-C64389840A81
P1343
Q21131082-514E8EF3-FF61-4604-A20B-78CA5514492DQ26772866-FC32485B-A098-4C7A-A894-C174A1B8716FQ27230115-A3749F0A-0D30-4203-88BC-D58B37CAC38CQ27973488-7312B098-703D-4392-943B-0AD8200EC5FAQ28543881-6FA410EC-F11A-4E10-A76C-AE060FE930ADQ28552661-21D146B6-6A4E-48FC-98D7-9E4A027D2700Q33701044-4AE8F08E-6700-4BDF-8160-1074BF1A8A08Q34514823-3C74D326-2622-4E16-926D-A534669CF512Q35264368-A3376EBC-0F07-4477-A35A-CB9F3F4DBD17Q35595561-5ED5074D-E26B-4F07-A8CE-E060023E9833Q35619891-BCB68CEB-563E-4986-86C3-24ECB7305D3CQ36004060-AD322E2F-F8FB-4CF4-A1E1-3B479BF0FDE3Q36049159-72E9D16C-167D-4CEF-9140-883612AA1403Q36053510-EB841C24-67F0-4BDA-844A-83B9C81FCB58Q36071335-E73C67E1-9080-44B2-94C7-892061695F34Q36160348-DF5FDAEB-A8AC-4DDB-A8B5-E2523A169E1CQ36182425-8857D6E3-3D02-4504-B02C-5EF567C62665Q36235726-593B1E77-B93D-4A0D-8619-27DDF80FE8CFQ36413834-31774321-88B3-4426-B825-9A16E2B4CD83Q36510147-C3475B4F-46CC-48C8-849B-EDB35AEF5961Q36717129-3F4FD175-61AB-4A48-B269-E0274C96DE36Q36728063-A8BCFCCB-2CB9-418C-932A-29B010B0B8D7Q37025030-F4DF1104-E362-4546-A590-1D3DC4D19546Q38260909-CF190378-9834-40C4-AEFB-6150F0529961Q39013988-8CDDDBA2-1AEE-4493-8275-6232AC3B2B89Q39041980-373E1C08-DB6B-461E-93F5-7740B075263AQ39296506-7EFB5740-DCAD-4550-9F94-6FC63CA77397Q40227597-A45EEFEB-55C5-43BA-BBA9-173A7699270BQ40715694-F50CFDC2-6151-4575-AA5F-7C1EAA18DD9EQ44482507-EE501A2A-3156-43DB-BAC6-34EE89BEEDE0Q45812682-1F37971E-DF0B-434C-A802-DDF843786B13Q47396685-D30B5671-BCFF-4543-815A-2948AD0B65E7Q56362278-39C24CF3-4F61-4410-BDCD-C6AC5CD9CEEBQ56365637-E8DFE203-25B4-4141-A2A5-0CC89E926296Q57144821-E85DA042-E18C-4D39-BA8B-92BA8409A66C
P2860
Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@ast
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@en
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@nl
type
label
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@ast
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@en
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@nl
prefLabel
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@ast
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@en
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Antibodies to PfSEA-1 block pa ...... tect against malaria infection
@en
P2093
Christen G DiPetrillo
Christian P Nixon
Dipak K Raj
Emily A McDonald
Grant Jolly
Hai-Wei Wu
Ian C Michelow
Jeffrey D Dvorin
Jonathan D Kurtis
P2860
P3181
P356
10.1126/SCIENCE.1254417
P407
P5008
P577
2014-05-23T00:00:00Z